Caladrius Biosciences, Inc. (LSTA) Tops Q1 EPS by 19c
Tweet
Share
E-mailGet Alerts LSTA Hot Sheet
Join SI Premium – FREE
Caladrius Biosciences, Inc. (NASDAQ: LSTA) reported Q1 EPS of ($0.55), $0.19 better than the analyst estimate of ($0.74).
For earnings history and earnings-related data on Caladrius Biosciences, Inc. (LSTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Hitachi Ltd. (HIT) Misses Q2 EPS by 7c
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
